Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the healthcare ecosystem, today announced that Keith Dunleavy, M.D., chief executive officer and chairman of the board of Inovalon, and Christopher Greiner, chief financial officer and chief operating officer of Inovalon, will present at the RBC Capital Markets Global Healthcare Conference on February 22, 2018, at the New York Palace Hotel in New York City.

Investors may access the conference materials on the Investor Relations section of Inovalon’s website at www.inovalon.com.

About Inovalon

Inovalon is a leading technology company providing cloud-based platforms empowering a data-driven transformation from volume-based to value-based models throughout the healthcare industry. Through the Inovalon ONE™ Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in petabyte volumes to arrive at sophisticated insights in real-time, drive impact wherever it is analytically identified best to intervene, and intuitively visualize data and information to inform business strategy and execution. Leveraging its platform, unparalleled proprietary data sets, and industry-leading subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon's unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Providing technology that supports nearly 500 healthcare organizations, Inovalon's platforms are informed by data pertaining to more than 903,000 physicians, more than 385,000 clinical facilities, and 231 million Americans. For more information, visit www.inovalon.com.

Contacts:Kim CollinsPhone: 301-809-4000 x1473                                 kcollins@inovalon.com

George Price (Investors)Phone: 301-809-4000 x1190gprice@inovalon.com

Inovalon (NASDAQ:INOV)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Inovalon Charts.
Inovalon (NASDAQ:INOV)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Inovalon Charts.